---
category: news
title: "Kiromic BioPharma Reports First Quarter 2021 Financial Results and Continued Corporate Progress"
excerpt: "Kiromic BioPharma achieved important scientific and operational milestones during the year that we believe have us well positioned for preparing our staff and our facilities for the first in-human dosing in Q3 2021,"
publishedDateTime: 2021-05-14T20:50:00Z
originalUrl: "https://www.businesswire.com/news/home/20210514005463/en/Kiromic-BioPharma-Reports-First-Quarter-2021-Financial-Results-and-Continued-Corporate-Progress"
webUrl: "https://www.businesswire.com/news/home/20210514005463/en/Kiromic-BioPharma-Reports-First-Quarter-2021-Financial-Results-and-Continued-Corporate-Progress"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "4c7lPRZ4LcjSAC1z7cAyqOXoF9/Y2/EHWW6FPZrcYylI0wjw6kgBLWI5T0/VKt5m2yTPjo4o8rP6379EdKcEmjNrv6jzjora2mQy5Q3ANOyjfS3XGmMExVKvkJngZcQU6Ecqc6EjUT2OrFrXG2WBFpHHO/dr09wBlmVMQcXaw+KQAdvJvO+tqxRiPTX5IaKgebEfGV6kuSYgG1eRnZ2YT3mqSHQYBd9oOo6+2BXoCA3apWTGTeQGIIvoH4t80ePe36Ymc0zZdZEb3RXLZ5Eh8Tigf9RaIN5irR1TGOncsRO5VeKuY63dlMLI1/0z5TCM0RyCF98WOY87wVBI5y3PnDQVaQmuYjLo9mX8EvmwdTk=;+sTnoM46cV2vA/DqHfZhoQ=="
---

